.png)
Lumara Bio Data Breach Lawsuit Investigation
Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in data breach cases, is investigating the Lumara Bio USA, Inc., a division of ITM data breach.
If you were affected by the data breach, your sensitive personally identifiable information may have been exposed, and you may be eligible for compensation.
About Lumara Bio USA
Lumara Bio USA, Inc. is the oncology therapeutics division of ITM Isotope Technologies Munich SE. The company focuses on developing targeted radiopharmaceutical therapies for cancers that are difficult to treat and have significant unmet medical needs.
Operating as the U.S. branch of ITM, Lumara Bio is headquartered in Princeton, New Jersey.
What Happened?
On Sept. 12, 2026, Lumara Bio discovered a cyberattack that affected certain ITM information technology systems.
The company took action by taking affected systems offline and engaging external cybersecurity experts to investigate the incident. The ongoing forensic investigation revealed unauthorized access to systems containing personal information of current and former Lumara Bio USA employees.
Written notices were mailed to affected individuals on Oct. 26, 2026.
Information Exposed:
- Social Security numbers
- Financial account information
- Driver’s licenses
- Names
- Addresses
- Dates of birth
- Driver’s license numbers
- Other government identification information
- Salary and compensation information
- Other employment-related information
You May Be Entitled to Compensation
If your information was compromised in the Lumara Bio data breach, you may be eligible for compensation. Lawyers are ready to help those affected understand their rights and pursue claims for damages related to this incident.
To find out if you qualify and to join a lawsuit, complete the below form.
.svg)